%0 Journal Article
%T Daclatasvir plus Sofosbuvir with or without ribavirin in patients with chronic Hepatitis C genotype 3a in Pakistani population - A real world experience
%A Syed Muhammad Ali Shah
%A Zamir Butt
%J Archive of "Pakistan Journal of Medical Sciences".
%D 2019
%R 10.12669/pjms.35.2.637
%X Pakistan is among leading countries of world in prevalence of chronic hepatitis C Daclatasvir plus sofosbuvir is recommended for treatment of CHC. The purpose of study was to determine the sustained virological response in patients with chronic viral hepatitis C genotype 3a irrespective of previous treatment experience or presence of liver cirrhosis
%K Chronic hepatitis C
%K Daclatasvir
%K Genotype 3a. Sofosbuvir
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500802/